-The Hindu CM criticises move to remove levy obligation on sugar mills Chennai: Chief Minister Jayalalithaa has strongly opposed the Centre's decision to remove the levy obligation on sugar mills, contending that it will impact on the public distribution system in the State. Under the levy obligation, as part of the regulation of the sugar sector, every sugar mill mandatorily surrenders 10 per cent of its production to the Central government at a...

-The Telegraph Rural development minister Jairam Ramesh has written to the Prime Minister for a rethink on a cabinet committee's recent clearances to two mining projects in Jharkhand's Saranda forests. Ramesh has argued that the projects would harm his ministry's Rs 300-crore development plan for the region, alienate local tribals and weaken the fight to contain the Maoists, a ministry official said. The Prime Minister heads the cabinet committee on infrastructure, which gave...

-The Business Standard Angelina Jolie has inadvertently highlighted a key question about patenting Angelina Jolies recent double mastectomy was obviously a very radical decision. It is unusual for a healthy person to opt for pre-emptive surgery to avert the probability, however high it may be, of getting cancer. The tests Jolie relied on are also at the heart of a legal battle, which could affect US biotech patenting norms. Since the US...

Argumentative Indians are at it again! After sparring over the poverty line and the actual number of poor, India's renowned economists have fired up a fresh debate over the extent of malnutrition. In the earlier debate, the Planning Commission ‘reduced' poverty on paper disregarding NSSO and official committees, including the NCEUS, which determined that 77% Indians survived on less than Rs 20 a day. Columbia university economist Arvind Panagariya has...

-The Hindu Seven years after the first warning in June 2006 from the U.S. Food and Drug Administration (FDA) and five years after the Department of Justice initiated legal proceedings against the company, Ranbaxy is back in the news for the same wrong reasons. Last fortnight it pleaded guilty to felony charges in the U.S., admitting to selling adulterated drugs with intent to defraud, not reporting that its drugs failed...